Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fudan University
Nationwide Children's Hospital
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
SOLTI Breast Cancer Research Group
National Cancer Institute (NCI)
Children's National Research Institute
National Cancer Institute (NCI)
Rain Oncology Inc
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Gustave Roussy, Cancer Campus, Grand Paris
University of Virginia
Charite University, Berlin, Germany
pharmaand GmbH
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Cambridge University Hospitals NHS Foundation Trust
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Columbia University
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GE Healthcare
National Cancer Institute (NCI)
University Hospital Muenster
Memorial Sloan Kettering Cancer Center